Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Soheila Korourian

Concepts (304)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
30
2018
1212
2.210
Why?
Carcinoma, Ductal, Breast
9
2015
90
1.470
Why?
Mastectomy, Segmental
8
2015
93
1.200
Why?
Catheter Ablation
4
2014
126
1.030
Why?
Neoplasm Recurrence, Local
7
2014
649
0.950
Why?
Sentinel Lymph Node Biopsy
15
2017
120
0.950
Why?
Mastectomy
10
2018
143
0.910
Why?
Mammary Neoplasms, Experimental
7
2010
122
0.820
Why?
Soybean Proteins
4
2023
162
0.790
Why?
Biopsy, Needle
11
2017
183
0.780
Why?
Obesity
8
2023
1162
0.770
Why?
Carcinoma in Situ
3
2008
72
0.750
Why?
Lymph Nodes
12
2017
258
0.730
Why?
Caseins
4
2023
78
0.720
Why?
9,10-Dimethyl-1,2-benzanthracene
4
2015
50
0.690
Why?
Liver
9
2023
1156
0.640
Why?
DNA, Neoplasm
1
2018
146
0.570
Why?
Isoflavones
5
2023
88
0.570
Why?
Rats, Zucker
9
2023
73
0.510
Why?
Uterine Cervical Neoplasms
3
2007
299
0.460
Why?
Receptor, erbB-2
3
2018
80
0.450
Why?
Receptors, Estrogen
4
2018
131
0.440
Why?
Aged
32
2018
10121
0.430
Why?
Arginine
1
2015
182
0.430
Why?
Dietary Supplements
2
2015
465
0.430
Why?
Neoplasm Staging
15
2015
772
0.420
Why?
Female
51
2018
28171
0.410
Why?
Middle Aged
34
2018
13028
0.410
Why?
Mammary Neoplasms, Animal
2
2015
35
0.390
Why?
Diet
2
2015
587
0.380
Why?
Ultrasonography, Mammary
4
2015
61
0.370
Why?
Carcinogens
3
2015
193
0.350
Why?
Antigens, Tumor-Associated, Carbohydrate
2
2008
24
0.350
Why?
Fatty Liver
3
2023
142
0.350
Why?
Benz(a)Anthracenes
1
2010
3
0.350
Why?
Dehydroepiandrosterone
1
2010
12
0.350
Why?
Rats
15
2023
3220
0.340
Why?
Axilla
9
2017
92
0.330
Why?
Lymphatic Vessels
4
2014
55
0.320
Why?
Aged, 80 and over
15
2018
3392
0.320
Why?
Plant Lectins
1
2008
8
0.300
Why?
Carcinoma, Ductal
1
2008
7
0.300
Why?
Adult
25
2018
14161
0.300
Why?
Prognosis
11
2017
2099
0.290
Why?
Magnetic Resonance Imaging
4
2014
1546
0.280
Why?
Technetium Tc 99m Sulfur Colloid
6
2014
31
0.280
Why?
Receptors, Progesterone
4
2018
66
0.280
Why?
Humans
48
2024
52483
0.280
Why?
Electrosurgery
1
2007
9
0.270
Why?
Clinical Competence
2
2024
406
0.270
Why?
Lymphedema
5
2017
48
0.270
Why?
Thinness
3
2017
44
0.270
Why?
Lymphatic Metastasis
12
2015
220
0.260
Why?
Cytodiagnosis
4
2015
43
0.260
Why?
Prospective Studies
12
2017
2481
0.250
Why?
Animals
19
2023
13505
0.250
Why?
Follow-Up Studies
10
2015
2279
0.250
Why?
Nipples
5
2013
33
0.250
Why?
Combined Modality Therapy
5
2014
639
0.240
Why?
Biopsy, Fine-Needle
4
2024
107
0.240
Why?
Adenocarcinoma, Mucinous
1
2005
20
0.240
Why?
Endometritis
1
2004
9
0.230
Why?
Ethanol
5
2010
342
0.230
Why?
Competency-Based Education
1
2024
29
0.230
Why?
Proteoglycans
1
2004
87
0.220
Why?
Radiopharmaceuticals
6
2014
204
0.220
Why?
Carcinoma, Intraductal, Noninfiltrating
3
2013
46
0.210
Why?
Proliferating Cell Nuclear Antigen
1
2003
69
0.210
Why?
Laser Coagulation
1
2003
27
0.210
Why?
Fellowships and Scholarships
1
2024
127
0.210
Why?
Membrane Glycoproteins
1
2004
244
0.210
Why?
Lymph Node Excision
6
2017
133
0.200
Why?
Plasma Cells
1
2004
239
0.200
Why?
Carcinoma, Lobular
3
2015
32
0.200
Why?
Neoplasm Invasiveness
5
2015
278
0.200
Why?
Coloring Agents
4
2014
69
0.200
Why?
Mammaplasty
2
2013
43
0.190
Why?
Infant Food
1
2002
28
0.190
Why?
Uterine Cervical Dysplasia
3
2007
51
0.190
Why?
Monitoring, Intraoperative
3
2014
54
0.180
Why?
Ovarian Neoplasms
1
2005
459
0.170
Why?
Immunohistochemistry
9
2017
979
0.170
Why?
Biopsy
4
2007
605
0.170
Why?
Ultrasonography, Interventional
3
2011
140
0.170
Why?
Paraffin Embedding
2
2018
52
0.160
Why?
Body Weight
3
2017
523
0.160
Why?
Sensitivity and Specificity
8
2015
891
0.160
Why?
Retrospective Studies
13
2015
6607
0.160
Why?
Lung Neoplasms
3
2015
636
0.160
Why?
Neoplasm Grading
3
2014
126
0.160
Why?
Adolescent
8
2015
6739
0.160
Why?
Tissue Fixation
1
2018
36
0.150
Why?
Specimen Handling
1
2018
56
0.150
Why?
Alanine Transaminase
3
2015
122
0.140
Why?
Rats, Sprague-Dawley
7
2015
1563
0.130
Why?
Treatment Outcome
5
2017
5422
0.120
Why?
Pulmonary Medicine
1
2015
16
0.120
Why?
Protein Hydrolysates
1
2015
7
0.120
Why?
Aspartate Aminotransferases
1
2015
49
0.120
Why?
Kaplan-Meier Estimate
2
2014
483
0.120
Why?
Rosaniline Dyes
1
2014
8
0.120
Why?
Sulfotransferases
1
2015
38
0.120
Why?
Image-Guided Biopsy
1
2015
34
0.120
Why?
Dermatologic Surgical Procedures
2
2013
35
0.120
Why?
Plant Extracts
1
2017
194
0.110
Why?
Melanoma
2
2011
288
0.110
Why?
Vacuum
2
2011
12
0.110
Why?
Ultrasonography, Doppler
1
2014
42
0.110
Why?
Interleukin-6
1
2015
278
0.110
Why?
Young Adult
6
2015
4329
0.110
Why?
Tumor Necrosis Factor-alpha
1
2015
399
0.100
Why?
Patient Care Planning
1
2013
68
0.100
Why?
Carcinoma, Adenoid Cystic
1
2013
5
0.100
Why?
Intraoperative Care
2
2011
51
0.100
Why?
Disease-Free Survival
1
2014
460
0.100
Why?
Preoperative Care
1
2014
173
0.100
Why?
Skin Neoplasms
2
2011
505
0.100
Why?
Lymphography
1
2011
10
0.090
Why?
Image Processing, Computer-Assisted
2
2003
253
0.090
Why?
Frozen Sections
1
2011
13
0.090
Why?
Liver Neoplasms
2
2005
333
0.090
Why?
Cytoprotection
1
2010
33
0.090
Why?
DNA Methylation
1
2015
592
0.090
Why?
Male
10
2023
26761
0.080
Why?
Fatty Liver, Alcoholic
1
2010
7
0.080
Why?
Drug Evaluation, Preclinical
1
2010
146
0.080
Why?
Genistein
1
2010
45
0.080
Why?
Feasibility Studies
1
2011
406
0.080
Why?
Cell Line, Tumor
3
2010
1470
0.080
Why?
Hepatocytes
2
2008
190
0.080
Why?
Pilot Projects
1
2011
721
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1031
0.080
Why?
Radionuclide Imaging
4
2011
107
0.070
Why?
Hepatitis
1
2008
20
0.070
Why?
Nuclear Magnetic Resonance, Biomolecular
1
2007
33
0.070
Why?
Cytokines
2
2008
623
0.070
Why?
Protons
1
2007
70
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2007
62
0.070
Why?
Ovariectomy
1
2007
113
0.070
Why?
Organ Size
1
2007
228
0.070
Why?
Oligosaccharides
1
2005
34
0.060
Why?
Cystadenocarcinoma, Papillary
1
2005
14
0.060
Why?
Antibodies, Neoplasm
1
2005
28
0.060
Why?
Omentum
1
2005
16
0.060
Why?
Aging
1
2010
701
0.060
Why?
Uterine Neoplasms
1
2005
60
0.060
Why?
Monosaccharide Transport Proteins
1
2004
14
0.060
Why?
Eosine Yellowish-(YS)
1
2004
6
0.060
Why?
Carcinoma, Small Cell
1
2004
26
0.060
Why?
Hematoxylin
1
2004
7
0.060
Why?
Syndecans
1
2004
37
0.060
Why?
Syndecan-1
1
2004
74
0.060
Why?
Endometrium
1
2004
43
0.060
Why?
Endotoxins
1
2004
21
0.060
Why?
Immunoenzyme Techniques
1
2004
137
0.060
Why?
Carbohydrates
1
2004
41
0.060
Why?
Lymphoma, Non-Hodgkin
1
2004
58
0.060
Why?
Liver Diseases, Alcoholic
1
2004
35
0.060
Why?
Pathology
1
2024
38
0.050
Why?
Cytological Techniques
1
2003
13
0.050
Why?
Apoproteins
1
2003
14
0.050
Why?
Neoplasms, Multiple Primary
1
2003
44
0.050
Why?
Fatty Acids
1
2004
149
0.050
Why?
Dietary Fats
1
2004
130
0.050
Why?
Malondialdehyde
1
2003
54
0.050
Why?
Gene Expression Regulation
1
2008
990
0.050
Why?
Gene Expression
2
2019
618
0.050
Why?
Cell Membrane
1
2004
245
0.050
Why?
Aldehydes
1
2003
81
0.050
Why?
Neoplasms
2
2004
1325
0.050
Why?
Overweight
1
2005
224
0.050
Why?
Cytochrome P-450 CYP2E1
3
2010
111
0.050
Why?
Risk Factors
1
2011
3889
0.050
Why?
Surgical Instruments
1
2002
28
0.050
Why?
Breast Diseases
1
2002
25
0.050
Why?
Foreign-Body Migration
1
2002
31
0.050
Why?
Hematoma
3
2010
65
0.050
Why?
Education, Medical, Graduate
1
2024
219
0.050
Why?
Asia
1
2002
20
0.050
Why?
Chronic Disease
1
2004
586
0.050
Why?
Carcinoma, Squamous Cell
1
2004
332
0.050
Why?
Cost-Benefit Analysis
2
2015
267
0.050
Why?
Head and Neck Neoplasms
1
2004
288
0.050
Why?
Time Factors
1
2007
2968
0.040
Why?
Neoplasm Metastasis
2
2015
243
0.040
Why?
Health Status
1
2002
294
0.040
Why?
Cytokine Receptor Common beta Subunit
1
2019
2
0.040
Why?
Methyltransferases
1
2019
29
0.040
Why?
Apoptosis
1
2005
1119
0.040
Why?
Disease Progression
2
2015
871
0.040
Why?
Child, Preschool
1
2008
4076
0.040
Why?
Alcohol Dehydrogenase
2
2010
38
0.040
Why?
Cohort Studies
2
2015
1542
0.040
Why?
Arm
2
2009
47
0.040
Why?
Oxidative Stress
3
2010
807
0.040
Why?
Stereotaxic Techniques
2
2010
40
0.040
Why?
Polymerase Chain Reaction
1
2019
461
0.040
Why?
Anti-Bacterial Agents
1
2004
807
0.040
Why?
Risk Assessment
2
2017
1327
0.030
Why?
Adiponectin
1
2017
46
0.030
Why?
Disease Models, Animal
2
2015
1478
0.030
Why?
Reproducibility of Results
2
2015
1229
0.030
Why?
Injections, Intralesional
2
2008
31
0.030
Why?
Feces
1
2017
153
0.030
Why?
Phylogeny
1
2017
231
0.030
Why?
Lipid Metabolism
1
2017
187
0.030
Why?
Leptin
1
2017
148
0.030
Why?
Cost Savings
1
2015
58
0.030
Why?
Child
1
2008
7248
0.030
Why?
Protective Agents
1
2015
17
0.030
Why?
Taxoids
1
2015
37
0.030
Why?
MCF-7 Cells
1
2015
64
0.030
Why?
Mice, Inbred BALB C
2
2005
312
0.030
Why?
Insulin
1
2017
479
0.030
Why?
CpG Islands
1
2015
121
0.030
Why?
Infant, Newborn
1
2002
2867
0.030
Why?
Cyclophosphamide
1
2015
171
0.030
Why?
Tumor Cells, Cultured
1
2015
460
0.030
Why?
Touch
1
2013
24
0.030
Why?
Neoadjuvant Therapy
1
2015
125
0.030
Why?
Biopsy, Large-Core Needle
1
2013
33
0.030
Why?
Carcinoma
1
2015
138
0.030
Why?
Angiogenesis Inhibitors
1
2015
183
0.030
Why?
Infant
1
2002
3733
0.030
Why?
Radiotherapy, Adjuvant
1
2013
63
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2015
236
0.030
Why?
Hormones
1
2013
59
0.030
Why?
Chemotherapy, Adjuvant
1
2013
124
0.030
Why?
Injections, Intradermal
1
2011
14
0.020
Why?
X-Rays
1
2011
55
0.020
Why?
Antineoplastic Agents
2
2013
1222
0.020
Why?
United States
1
2002
5192
0.020
Why?
Cicatrix
1
2011
42
0.020
Why?
Intraoperative Period
1
2011
46
0.020
Why?
Diagnosis, Differential
2
2004
1046
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2015
857
0.020
Why?
Allyl Compounds
1
2010
11
0.020
Why?
Predictive Value of Tests
2
2004
944
0.020
Why?
Sulfides
1
2010
29
0.020
Why?
Survival Rate
1
2012
945
0.020
Why?
Chemokines
1
2010
79
0.020
Why?
Transforming Growth Factor beta1
1
2010
62
0.020
Why?
Double-Blind Method
1
2011
713
0.020
Why?
Mammary Glands, Animal
1
2010
69
0.020
Why?
Endoplasmic Reticulum
1
2010
111
0.020
Why?
Cell Division
1
2010
291
0.020
Why?
Pyrazoles
1
2010
114
0.020
Why?
Pregnancy
1
2015
2680
0.020
Why?
Tissue Extracts
1
2007
13
0.020
Why?
Least-Squares Analysis
1
2007
44
0.020
Why?
Biotransformation
1
2007
85
0.020
Why?
Enzyme Inhibitors
1
2010
372
0.020
Why?
Electrocoagulation
1
2007
12
0.020
Why?
Survival Analysis
1
2009
673
0.020
Why?
Solubility
1
2007
79
0.020
Why?
Observer Variation
1
2007
134
0.020
Why?
Staining and Labeling
1
2007
97
0.020
Why?
Enteral Nutrition
1
2008
154
0.020
Why?
Positron-Emission Tomography
1
2008
301
0.020
Why?
E-Selectin
1
2005
13
0.020
Why?
Body Weights and Measures
1
2005
17
0.020
Why?
Wheat Germ Agglutinins
1
2005
3
0.020
Why?
Vaccines, DNA
1
2005
11
0.020
Why?
Vaccines, Subunit
1
2005
15
0.020
Why?
Gadolinium
1
2005
44
0.020
Why?
Cross Reactions
1
2005
41
0.020
Why?
Growth Inhibitors
1
2005
26
0.010
Why?
Cytotoxicity, Immunologic
1
2005
58
0.010
Why?
Ligands
1
2005
206
0.010
Why?
Gene Amplification
1
2005
58
0.010
Why?
Mice
2
2005
5949
0.010
Why?
Glucose Transporter Type 1
1
2004
17
0.010
Why?
Imaging, Three-Dimensional
1
2005
154
0.010
Why?
Free Radicals
1
2004
28
0.010
Why?
Sampling Studies
1
2004
38
0.010
Why?
In Situ Hybridization, Fluorescence
1
2005
263
0.010
Why?
Enzyme Induction
1
2004
77
0.010
Why?
Corn Oil
1
2004
12
0.010
Why?
Eye Neoplasms
1
2004
8
0.010
Why?
Contrast Media
1
2005
193
0.010
Why?
MART-1 Antigen
1
2004
12
0.010
Why?
Hyperplasia
1
2004
98
0.010
Why?
Amino Acid Sequence
1
2005
578
0.010
Why?
Species Specificity
1
2004
192
0.010
Why?
Rats, Wistar
1
2004
193
0.010
Why?
Necrosis
1
2004
176
0.010
Why?
Injections
1
2003
61
0.010
Why?
Molecular Sequence Data
1
2005
778
0.010
Why?
Cell Proliferation
1
2008
1023
0.010
Why?
Dietary Carbohydrates
1
2004
90
0.010
Why?
Regression Analysis
1
2004
401
0.010
Why?
Cytoplasm
1
2004
94
0.010
Why?
Cytochrome P-450 Enzyme System
1
2004
191
0.010
Why?
Energy Intake
1
2004
174
0.010
Why?
Cell Nucleus
1
2004
187
0.010
Why?
Multivariate Analysis
1
2004
591
0.010
Why?
Antigens, Neoplasm
1
2004
147
0.010
Why?
Glutathione
1
2004
305
0.010
Why?
Sex Characteristics
1
2004
198
0.010
Why?
Antioxidants
1
2004
256
0.010
Why?
Confidence Intervals
1
2002
158
0.010
Why?
Models, Theoretical
1
2002
185
0.010
Why?
Neoplasm Proteins
1
2004
334
0.010
Why?
Reoperation
1
2002
465
0.010
Why?
Korourian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description